Atlas Trials

Study of AGN-190584 Eye Drops to Assess Safety and Efficacy in Participants Aged 40-80 Years With Pseudophakic Presbyopia

Clinical trial NCT05393089 · WITHDRAWN

Trial details

NCT number
NCT05393089
Sponsor
Allergan
Status
WITHDRAWN
Phase
Phase 2
Study type
INTERVENTIONAL
Presbyopia
Start date
2022-06-09
Primary completion
2023-04-04
Enrollment
0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.